ALLEGAN — Perrigo Co. plc reaffirmed its 2019 earnings guidance and reported a slight decline in net sales resulting from unfavorable currency translations and exited businesses.
ALLEGAN — Perrigo Co. plc today closed on the $750 million cash acquisition of Grand Rapids-based Ranir Global Holdings LLC.
GRAND RAPIDS — Executives at Ranir Global Holdings LLC put a plan in place four years ago to grow the company and prepare for investors’ eventual exit. By 2018, as the world’s largest producer of private-label store-brand oral care products grew sales and earnings at double-digit rates, management started exploring various options, including the potential for an IPO.
ALLEGAN — The sweeping transformation plan from Perrigo Co. plc President and CEO Murray Kessler aims to return the company to higher sales and earnings growth within a few years. Murray envisions a Perrigo that’s focused on “self-care,” producing products for consumers not only to treat themselves with store-brand, over-the-counter medications but also to maintain their health and prevent illness.
Perrigo Co. plc plans to “separate” its generic drug business that’s faced significant price pressure and generated lower sales.
ALLEGAN — As Perrigo Co. plc transitions to a new CEO, John Hendrickson thinks the company is “positioned in exactly the right place.”
Uwe Rohrhoff, a veteran pharmaceutical industry executive who previously ran Germany’s Gerresheimer AG, was named today as the new president and CEO at Perrigo Co. plc.
ALLEGAN — Perrigo. Co. plc wants the federal government to pay back more than $163.5 million in taxes it paid over four years.